source
- Antibody-drug conjugates poised to move lung cancer treatment earlier, boosting response rates and targeting brain metastasesExperts highlight that antibody‑drug conjugates are reshaping non‑small cell lung cancer therapy, moving beyond their traditional role in later‑line settings. The new agents have demonstrated high…
- Endpoints Weekly highlights biotech company models, a quirky startup story, and earnings season updatesThe latest edition of Endpoints Weekly introduces a look at emerging biotech company structures, noting how new models are reshaping the industry. It also features a light‑hearted piece about a st…